Structural basis for ALK2/BMPR2 receptor complex signaling through kinase domain oligomerization

Area of Science:

• Biochemistry
• Molecular Biology
• Cell Signaling

Background:

• Bone morphogenetic protein (BMP) receptors assemble into tetrameric complexes upon ligand binding to initiate SMAD signaling.
• The precise mechanism linking BMP receptor tetramerization to kinase activation remains unclear.

Purpose of the Study:

• To elucidate the structural basis of BMP receptor activation and its role in pulmonary arterial hypertension (PAH).
• To investigate the initial steps of receptor complex formation involving type I and type II BMP receptors.

Main Methods:

• Hydrogen deuterium exchange mass spectrometry (HDX-MS)
• Small-angle X-ray scattering (SAXS)
• Molecular dynamics (MD) simulations
• SMAD signaling pathway analysis

Main Results:

• Type I (ALK2) and type II (BMPR2) receptor kinases form a heterodimeric complex through their C-terminal lobes.
• This heterodimerization is critical for ligand-induced signaling and is implicated in BMPR2 mutations found in PAH patients.
• The type I/II kinase heterodimer acts as a scaffold for tetrameric complex assembly, facilitating GS domain phosphorylation and SMAD activation.

Conclusions:

• BMP receptor activation initiates with the formation of a type I/II kinase heterodimer.
• This heterodimerization is a key regulatory step in BMP signaling and a potential therapeutic target for PAH.